Proteomics offers significant hope as a cancer diagnostic tool, but while the earlier study appears promising, the results must be validated. To do this, we'll begin studying proteomics using blood from women who have had ovarian cancer to see if we can identify a specific protein pattern in those women whose cancers may later recur.
|